• <a  data-cke-saved-href='mailto:GLC@omegadiagnostics.co.uk' href='mailto:GLC@omegadiagnostics.co.uk' target='_blank'>Global Learning Centre for VISITECT<sup>®</sup> CD4 Advanced Disease e-learning. Contact us to register for our new online e-learning.</a>
  • <a  data-cke-saved-href='/Products/COVID-19/VISITECT-COVID-19-Antigen-Test' href='/Products/COVID-19/VISITECT-COVID-19-Antigen-Test' > Omega Diagnostics launches VISITECT<sup>®</sup> COVID-19 Antigen, a rapid test to identify an active SARS-CoV-2 infection.
  • <a  data-cke-saved-href='/Portals/0/ODX%20-%20UK%20Public%20Sector%20Antigen%20Contract%20disclosure%20%2815_03_21%29.pdf' href='/Portals/0/ODX%20-%20UK%20Public%20Sector%20Antigen%20Contract%20disclosure%20%2815_03_21%29.pdf' target='_blank'> Omega's contract with DHSC to provide manufacturing capacity for COVID-19 lateral flow antigen tests estimated at £374 million.</a>
  • <a  data-cke-saved-href='https://www.omegadiagnostics.com/Portals/0/ODX%20-%20Screen4%20Contract%20for%20Lab%20testing%20service%20%2802_03_21%29.pdf' href='https://www.omegadiagnostics.com/Portals/0/ODX%20-%20Screen4%20Contract%20for%20Lab%20testing%20service%20%2802_03_21%29.pdf'target='_blank'> Omega signs contract with Screen4 to provide COVID-19 antibody laboratory-based testing service</a>
  • <a  data-cke-saved-href='/Portals/0/200428%20-%20Supply%20Agreement%20with%20Clinton%20Health%20Access%20Initiative%2C%20Inc_.pdf' href='/Portals/0/200428%20-%20Supply%20Agreement%20with%20Clinton%20Health%20Access%20Initiative%2C%20Inc_.pdf' target='_blank'>Omega Diagnostics partners with Unitaid and the Clinton Health Access Initiative to increase access to CD4 testing for people living with HIV in low- and middle-income countries.</a>
  • <a  data-cke-saved-href='https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0230453&type=printable' href='https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0230453&type=printable' target='_blank'>Independent MSF evaluation on VISITECT<sup>®</sup> CD4 Advanced Disease in Malawi, Zimbabwe and the Democratic Republic of Congo published.</a>

Allergy

COVID-19

We are meeting the demand for both point-of-care and laboratory-based tests for COVID-19 diagnostics

Visitect CD4

Global Health

Focus on unique VISITECT® CD4 rapid tests enabling access to people living with HIV in low- and middle-income countries

Food Intolerance

Food Intolerance

Point-of-care and laboratory-based solutions for food intolerance and gut health

Latest News

Interim results for the six months ended 30 September 2021

Click here to read our unaudited interim results for the six months ended 30 September 2021

Read more

Upcoming Events

ICASA, 6-11 December 2021

Durban, South Africa